Covance Inc., the Princeton-based provider of drug development services, announced Tuesday it has entered into a note purchase agreement for the private placement of senior notes totaling $250 million with a group of institutional investors.
According to the announcement, the notes are expected to be issued in November 2013 in the following four series:
- $15 million bearing interest at 3.25% and maturing on November 15, 2018;
- $50 million bearing interest at 3.90% and maturing on November 15, 2020;
- $90 million bearing interest at 4.50% and maturing on November 15, 2023; and
- $95 million bearing interest at 4.65% and maturing on November 15, 2025.
Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.View Comment Policy